Recruiting

Hemostasis EvaluationEvaluation of Hemostasis in Bleeding and Thrombotic Disorders

Sponsor:

The University of Texas Health Science Center, Houston

Code:

NCT00178594

Conditions

Blood Coagulation Disorders, Inherited

Thrombotic Disorder

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.

Conditions

Blood Coagulation Disorders, Inherited

Thrombotic Disorder

Study ID

NCT00178594

Start date

Oct, 2002

Status verified date

Dec, 2024

Completion date

Jan, 2028

Anticipated

Primary completion date

Jan, 2028

Anticipated

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria: patients with congenital or acquired bleeding or clotting disorders who have provided informed consent and/or assent

Exclusion Criteria: poor venous access

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

Assess primary and secondary hemostasis in individuals with bleeding and clotting disorders [ Time Frame: 24 hours ]

Central Contacts and Locations

Central contacts

Katherine Addy, RN, BSN, MPH

713-500-8352 Katherine.E.Addy@uth.tmc.edu

Daisy Garcia, RN, BSN

713-500-8386 daisy.r.garcia@uth.tmc.edu

Locations

The Univerisity of Texas Health Science Center at Houston

Recruiting

Houston, Texas, United States, 77030

Contacts

Katherine Addy, RN, BSN, MPH

713-500-8352 Katherine.E.Addy@uth.tmc.edu

UT Physicians Women's Center-Texas Medical Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Randa Jalloul, MD

(832) 325-7131 randa.j.jalloul@uth.tmc.edu

More Information

Sponsor

The University of Texas Health Science Center, Houston

Last update posted

Jan 9, 2025

Last verified

Dec, 2024

Keywords

Hereditary Bleeding disorder
Thrombotic Disorder

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The University of Texas Health Science Center, Houston on 2025-01-09.